EDGAR Filing Documents for 0001628280-17-007796

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001628280-17-007796

Filing Date

2017-08-02

Accepted

2017-08-01 18:15:25

Documents

Period of Report

2017-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	rgls20170630-10q.htm	10-Q	947117
2	EXHIBIT 10.1	ex-101xdeegmarkemploymenta.htm	EX-10.1	103765
3	EXHIBIT 10.2	ex-102xhaganjaybasesalarya.htm	EX-10.2	1756
4	EXHIBIT 10.3	ex-103xgrintpaulseparation.htm	EX-10.3	111187
5	EXHIBIT 31.1	ex-311x20170630.htm	EX-31.1	12043
6	EXHIBIT 31.2	ex-312x20170630.htm	EX-31.2	12071
7	EXHIBIT 32.1	ex-321x20170630.htm	EX-32.1	11538
14		paulgrintseparationag_image1.gif	GRAPHIC	51059
	Complete submission text file	0001628280-17-007796.txt		4517965

Data Files

Seq	Description	Document	Type	Size
8	XBRL INSTANCE DOCUMENT	rgls-20170630.xml	EX-101.INS	842977
9	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	rgls-20170630.xsd	EX-101.SCH	31325
10	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	rgls-20170630_cal.xml	EX-101.CAL	51588
11	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	rgls-20170630_def.xml	EX-101.DEF	144915
12	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	rgls-20170630_lab.xml	EX-101.LAB	432661
13	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	rgls-20170630_pre.xml	EX-101.PRE	240663

Mailing Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121

Business Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121 858-202-6300

Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)